- Filed
- Mar 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2025 · Dec 31, 2025 | 58.7M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 63.14M sh |
| Capex | FY 2025 · Dec 31, 2025 | $2.05M |
| Capex restated | FY 2025 · Dec 31, 2024 | $31K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$19.58M |
| Operating Cash Flow restated | FY 2025 · Dec 31, 2024 | $15.44M |
| Long Term Debt | FY 2025 · Dec 31, 2025 | $67.45M |
| Short Term Debt | FY 2025 · Dec 31, 2025 | $78.2M |
| Short Term Debt restated | FY 2025 · Dec 31, 2024 | $50.2M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $24.42M |
| Cash And Equivalents restated | FY 2025 · Dec 31, 2024 | $22.63M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $57.37M |
| Stockholders Equity restated | FY 2025 · Dec 31, 2024 | $66.87M |
| Stockholders Equity restated | FY 2025 · Dec 31, 2023 | −$31.18M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $219.26M |
| Total Liabilities restated | FY 2025 · Dec 31, 2024 | $198.51M |
| Total Assets | FY 2025 · Dec 31, 2025 | $276.63M |
| Total Assets restated | FY 2025 · Dec 31, 2024 | $265.38M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$0.28 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | $0.90 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$0.28 |
| Eps Basic | FY 2025 · Dec 31, 2024 | $0.96 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $71.77M |
| Sga Expense restated | FY 2025 · Dec 31, 2024 | $74.7M |
| Net Income | FY 2025 · Dec 31, 2025 | −$16.25M |
| Net Income restated | FY 2025 · Dec 31, 2024 | $46.91M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$29K |
| Operating Income restated | FY 2025 · Dec 31, 2024 | $5.13M |
| Gross Profit | FY 2025 · Dec 31, 2025 | $71.74M |
| Gross Profit restated | FY 2025 · Dec 31, 2024 | $79.83M |
| Revenue | FY 2025 · Dec 31, 2025 | $406.69M |
| Revenue restated | FY 2025 · Dec 31, 2024 | $463.71M |